StonvexLoading…
StonvexStonvexStonvexCore line items from CZR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.49B | $11.24B | $11.53B | $10.82B |
Operating Income | $1.86B | $2.30B | $2.47B | $1.74B |
Net Income | $-502.00M | $-278.00M | $786.00M | $-899.00M |
EPS (Diluted) | $-2.42 | $-1.29 | $3.64 | $-4.19 |
Total Assets | $31.64B | $32.59B | $33.37B | $33.53B |
Total Liabilities | $27.95B | $28.21B | $28.65B | $29.78B |
Cash & Equivalents | $887.00M | $866.00M | $1.00B | $1.04B |
Free Cash Flow OCF − CapEx | $497.00M | $-221.00M | $545.00M | $41.00M |
Shares Outstanding | 202.63M | 211.33M | 215.80M | 214.67M |